scholarly journals Effects of ovariectomy and oestradiol-17beta replacement on brain tyrosine hydroxylase in the catfish Heteropneustes fossilis: changes in in vivo activity and kinetic parameters

2002 ◽  
Vol 175 (2) ◽  
pp. 329-342 ◽  
Author(s):  
R Chaube ◽  
KP Joy
Keyword(s):  
Body Weight ◽  
Tyrosine Hydroxylase ◽  
Brain Regions ◽  
Inhibitory Effect ◽  
Heteropneustes Fossilis ◽  
Gonadotrophin Secretion ◽  
Tyrosine Hydroxylation ◽  
Brain Tyrosine Hydroxylase ◽  
Biphasic Responses

In Heteropneustes fossilis, ovariectomy inhibited in vivo brain (hypothalamus-pituitary, telencephalon and medulla oblongata) tyrosine hydroxylase (TH) activity with significant effects in weeks 2, 3, 4 and 5 of the gonadal resting phase and in weeks 3, 4 and 5 of the prespawning phase (P<0.05, Tukey's test). Oestradiol-17beta (OE(2)) replacement in 3-week ovariectomised fish produced biphasic responses in both seasons; the low dosages of 0.05 and 0.5 micro g/g body weight (BW) elevated TH activity, whereas the high dosages of 1.0 and 2.0 micro g/g BW decreased it. The magnitude of the inhibition was higher in the resting phase than in the prespawning phase. The inhibitory effect of ovariectomy may be produced by elevating the apparent K(m) values (decreased affinity) of the enzyme for both L-tyrosine (substrate) and dimethyltetrahydropteridine (cofactor) and consequently decreasing the V(max). Significant changes (P<0.05) in both these parameters were noticed but showed minor differences with regard to the length of ovariectomy, season or brain regions. The biphasic effects of OE(2) replacement on TH activity seemed to be produced by differential effects on apparent K(m) and V(max). The stimulatory effect of the low dosages of OE(2) coincides with a decrease in the apparent K(m) values (increased affinity) for both substrate and cofactor and an increase in the V(max) of the enzyme. The inhibitory effect of the high dosages of OE(2) correlated with an increase in the apparent K(m) values (decreased affinity) for both substrate and cofactor, and a decrease in the V(max) compared with the lower dosage groups. The results strongly suggested that OE(2) can modulate brain catecholaminergic activity at the level of tyrosine hydroxylation which, in turn, may alter gonadotrophin secretion. OE(2) may elicit biphasic effects by differentially altering the enzyme affinity towards the substrate and cofactor.

scholarly journals Thyroid hormone modulation of brain in vivo tyrosine hydroxylase activity and kinetics in the female catfish Heteropneustes fossilis

2003 ◽  
Vol 179 (2) ◽  
pp. 205-215 ◽  
Author(s):  
R Chaube ◽  
KP Joy
Keyword(s):  
Tyrosine Hydroxylase ◽  
Medulla Oblongata ◽  
Kinetic Studies ◽  
Brain Regions ◽  
Kinetic Properties ◽  
Dependent Manner ◽  
Apparent Velocity ◽  
Heteropneustes Fossilis ◽  
Hormone Modulation

In the female catfish Heteropneustes fossilis, administration of thyroxine (T(4))(,) 1 micro g/g body weight, i.p., in both gonadal resting and preparatory phases for 7, 14 and 21 days caused hyperthyroidism, as evidenced from a duration-dependent significant increase in serum triiodothyronine (T(3)), and of tyrosine hydroxylase (TH) activity in telencephalon, hypothalamus-pituitary and medulla oblongata (Newman-Keuls' test; P<0.05). Hypothyroidism induced by adding 0.03% thiourea to aquarium water holding the catfish for 7, 14 and 21 days decreased serum T(3) levels in a duration-dependent manner (Newman-Keuls' test; P<0.05) and inhibited TH activity in the brain regions. T(4) replacement in 21day thiourea-treated fish restored and even elevated significantly serum T(3) levels as well as brain TH activity in a duration-dependent manner. In general, the changes in enzyme activity were higher in the forebrain regions than medulla oblongata and in the resting phase than preparatory phase. Kinetic studies by Lineweaver-Burk plots showed that the stimulatory effect following T(4) administration and T(4) replacement on TH activity was due to increased affinity of the enzyme for its cofactor (6,7-dimethyl-2-amino-4-hydroxy-5,6,7,8-tetrahydropteridine), as evident from a significant decrease in apparent Michaelis-Menten constant (K(m)) and an increase in apparent velocity maximum (V(max)). The TH inhibition due to the thiourea treatment can be related to decreased affinity of the enzyme for its cofactor, as evident from a significant increase in apparent K(m) value and a significant decrease in V(max). These data clearly show that circulating levels of T(4)/T(3) modulate brain TH activity by altering the kinetic properties of the enzyme, which, in turn, influence catecholaminergic activity and dependent functions.

Phytochemical Screening and Anti-Diabetic Efficacy of O. Sanctum Seed Extract on Streptozotocin Induced Diabetic Rats

2017 ◽  
Vol 54 (3) ◽  
pp. 336
Author(s):  
Kavitha K. ◽  
Ponne S.
Keyword(s):  
Body Weight ◽  
Digestive Enzymes ◽  
Fasting Blood Glucose ◽  
Inhibitory Effect ◽  
Diabetic Rats ◽  
Seed Extract ◽  
Phytochemical Screening ◽  
Weight Changes

The present study was designed to assess the in vitro and in vivo anti-diabetic efficacy of <em>O. sanctum</em> seed and its phytochemical screening. In vitro inhibitory effect on carbohydrate digestive enzymes like α-amylase and α-glucosidase and in vivo parameters such as fasting blood glucose and body weight changes were studied, a potent inhibitory effect was observed on activities of digestive enzymes and a marked decrease in the glucose level in the <em>O. sanctum</em> seed extract treated streptozotocin induced diabetic rats was noted. Further a marked reduction in body weight was also observed.

Growth hormone (GH) autofeedback action in the neonatal rat: involvement of GH-releasing hormone and somatostatin

1990 ◽  
Vol 124 (2) ◽  
pp. 199-205 ◽  
Author(s):  
S. G. Cella ◽  
V. De Gennaro Colonna ◽  
V. Locatelli ◽  
V. Moiraghi ◽  
S. Loche ◽  
...  
Keyword(s):  
Body Weight ◽  
Inhibitory Effect ◽  
Postnatal Period ◽  
Neonatal Rat ◽  
Gh Treatment ◽  
Adult Rats ◽  
Releasing Hormone ◽  
Term Administration

ABSTRACT It is known that in adult rats, GH by itself and by promoting secretion of the somatomedins acts at the level of the hypothalamus to trigger release of somatostatin and decrease output of GH-releasing hormone (GHRH), thereby inhibiting further secretion of GH. To assess whether these mechanisms are already operative in the early postnatal period, we have evaluated the effect of short-term administration of GH in 10-day-old rats. Twice-daily s.c. administration of 25 μg human GH/rat, from days 5 to 9 of life, significantly reduced pituitary content of GH, decreased hypothalamic levels of GHRH mRNA and abolished the in-vivo GH response to a challenge dose of GHRH (20 ng/100 g body weight, s.c.). GHRH (20 ng/100 g body weight, twice daily, s.c.) given concomitantly with the GH treatment, completely counteracted the inhibitory effect of the latter on pituitary content of GH and restored to normal the in-vivo GH response to the GHRH challenge. These data indicate that impaired secretion of GHRH is involved in the inhibitory effect elicited by GH treatment in infant rats. However, concomitant involvement of hypothalamic somatostatin as a result of GH treatment cannot be ruled out. In fact, pituitaries from rats pretreated with GH responded in the same manner as pituitaries from control rats to the GHRH challenge in vitro. Journal of Endocrinology (1990) 124, 199–205

Inhibitory effects of (-)-Epigallocatechin-3-gallate from green tea on the growth of Babesia parasites

Parasitology ◽  
2009 ◽  
Vol 137 (5) ◽  
pp. 785-791 ◽  
Author(s):  
M. ABOULAILA ◽  
N. YOKOYAMA ◽  
I. IGARASHI
Keyword(s):  
Body Weight ◽  
Green Tea ◽  
Inhibitory Effect ◽  
Post Inoculation ◽  
Chemotherapeutic Drug ◽  
Inhibitory Effects ◽  
Viability Test ◽  
Anti Cancer

SUMMARY(-)-Epigallocatechin-3-gallate (EGCG) is the major tea catechin and accounts for 50–80% of the total catechin in green tea. (-)-Epigallocatechin-3-gallate has antioxidant, anti-inflammatory, anti-microbial, anti-cancer, and anti-trypanocidal activities. This report describes the inhibitory effect of (-)-Epigallocatechin-3-gallate on the in vitro growth of bovine Babesia parasites and the in vivo growth of the mouse-adapted rodent babesia B. microti. The in vitro growth of the Babesia species was significantly (P<0·05) inhibited in the presence of micromolar concentrations of EGCG (IC50 values=18 and 25 μM for B. bovis, and B. bigemina, respectively). The parasites showed no re-growth at 25 μM for B. bovis and B. bigemina in the subsequent viability test. The drug significantly (P<0·05) inhibited the growth of B. microti at doses of 5 and 10 mg/kg body weight, and the parasites completely cleared on day 14 and 16 post-inoculation in the 5 and 10 mg/kg treated groups, respectively. These findings highlight the potentiality of (-)-Epigallocatechin-3-gallate as a chemotherapeutic drug for the treatment of babesiosis.

Sign in / Sign up

Export Citation Format

Share Document